Skip to main content

CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC

For the period ended Dec 31, 2023. Filed Mar 22, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 22, 2024

CELZ$0.61-1.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Part II

PART II – OTHER INFORMATION

On June 12, 2023, we announced that our Board of Directors authorized a share repurchase program for the repurchase of up to $2 million of our common stock (the “Repurchase Plan). Purchases under the Repurchase Plan commenced in August 2023. The following table provides information about our monthly share repurchases for the year ended December 31, 2023, which consisted solely of repurchases on the open market under the Repurchase Plan.

ISSUER PURCHASES OF EQUITY SECURITIES
Period · Total Number of Shares Purchased · Average Price Paid per Share · Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs · Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
July 1 - July 31, 2023-$-0$2,000,000
August 1 - August 31, 202311,5004.5711,5001,947,462
September 1 - September 30, 202328,5004.8940,0001,755,682
October 1 – October 31, 20236,5004.6846,5001,725,269
November 1 – November 31, 20238,0004.4154,5001,689,959
December 1 – December 31, 20233,0004.4857,5001,676,510
Total57,5004.71
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.